“Antiepileptic drugs often produce serious adverse effects, and many patients do not respond to them properly.
Phytocannabinoids produce anticonvulsant effects in preclinical and preliminary human studies, and appear to produce fewer adverse effects than available antiepileptic drugs.
The present review summarizes studies on the anticonvulsant properties of phytocannabinoids.
Preclinical studies suggest that phytocannabinoids, especially cannabidiol and cannabidivarin, have potent anticonvulsant effects which are mediated by the endocannabinoid system. Human studies are limited in number and quality, but suggest that cannabidiol has anticonvulsant effects in adult and infantile epilepsy and is well tolerated after prolonged administration…
Phytocannabinoids produce anticonvulsant effects through the endocannabinoid system, with few adverse effects.”